Evidence map›Paper›PMID 42903947›Full record

ArticleRSC chemical biology2026

Bromo-desthiobiotin (Br-DTB) tag for unbiased profiling and identification of chemical modifications.

Bibhuti Bhusana Palai, Daniel H Ramirez, Changfeng Deng, Francisca N de Luna Vitorino, Chenfeng Zhao, Dong Zhu, Dongwen Lv, Benjamin A Garcia, Zongtao Lin

Abstract read
In one paragraph

Article in RSC chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bibhuti Bhusana PalaiDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine in St. Louis MO 63110 USA bagarcia@wustl.edu.
Daniel H RamirezDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine in St. Louis MO 63110 USA bagarcia@wustl.edu.
Changfeng DengDepartment of Medicinal Chemistry, Rutgers University Piscataway NJ 08854 USA tom.z.lin@rutgers.edu.
Francisca N de Luna VitorinoDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine in St. Louis MO 63110 USA bagarcia@wustl.edu.
Chenfeng ZhaoDepartment of Medicinal Chemistry, Rutgers University Piscataway NJ 08854 USA tom.z.lin@rutgers.edu.
Dong ZhuDepartment of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University Augusta Georgia 30912 USA.
Dongwen LvDepartment of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University Augusta Georgia 30912 USA.
Benjamin A GarciaDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine in St. Louis MO 63110 USA bagarcia@wustl.edu.ORCID https://orcid.org/0000-0003-3596-4750
Zongtao LinDepartment of Medicinal Chemistry, Rutgers University Piscataway NJ 08854 USA tom.z.lin@rutgers.edu.ORCID https://orcid.org/0000-0002-6017-338X

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Chang S Chan · 1997 to 2026
$94.5M
A Mass Spectrometry Approach to the Genetic and Epigenetic Mechanisms Controlling Neuronal IdentityR01NS111997 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI DAHMANE, NADIA, GARCIA, BENJAMIN A · 2020 to 2024
$2.6M
Development and Application of Chemical Biology Approaches for Understanding Protein ArginylationR01HL177113 · NHLBI · WASHINGTON UNIVERSITY · PI Benjamin A Garcia, Zongtao Lin · 2025 to 2026
$1.2M
Hijacking Post-translational Arginylation for Targeted Protein DegradationR21CA292191 · NCI · WASHINGTON UNIVERSITY · PI LIN, ZONGTAO, LYU, DONGWEN · 2024 to 2024
$426k
Development of Caspase Cleavage Targeting Chimeras (CACTACs) for Targeted Protein Cleavage.R21CA286307 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LYU, DONGWEN · 2024 to 2025
$409k
NCI NIH HHS P30 CA072720NCI NIH HHS R21 CA286307NCI NIH HHS R21 CA292191NHLBI NIH HHS R01 HL177113NINDS NIH HHS R01 NS111997
6 · The paper itself

Abstract

Leveraging the intrinsic reactivity of cysteine, isoTOP-ABPP (activity-based protein profiling) has been a powerful chemoproteomic platform for cysteine quantification, ligand, and chemical modification discovery. Here, we report new bromo-desthiobiotin azide (Br-DTB) tags for covalent labelling, enabling unbiased identification of chemical modifications. Besides peptide identification from MS2 spectra, Br's isotopic MS1 signatures provide an additional layer of validation to confirm labelled sites and eliminate false-positive assignments. To support this analysis, we have developed a publicly available in-house software to automatically recognize this isotopic signature. The accuracy of the Br-DTB tag was further validated by a synthetic peptide

Identifiers

PMID42903947
PMCPMC13682531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.